Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cambrex Corp (CBM)

Cambrex Corp (CBM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,023,102
  • Shares Outstanding, K 33,724
  • Annual Sales, $ 532,090 K
  • Annual Income, $ 92,420 K
  • 60-Month Beta 2.13
  • Price/Sales 3.80
  • Price/Cash Flow 15.36
  • Price/Book 2.99
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.60
  • Most Recent Earnings 0.31 on 05/02/19
  • Next Earnings Date 11/14/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 14.000 on 05/04/07
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.04
  • Growth Rate Est. (year over year) +2,497,400.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
59.72 +0.45%
on 11/04/19
59.99 unch
on 12/03/19
+0.19 (+0.32%)
since 11/01/19
3-Month
59.38 +1.03%
on 10/02/19
60.14 -0.25%
on 09/06/19
+0.43 (+0.72%)
since 09/03/19
52-Week
33.80 +77.49%
on 02/14/19
60.29 -0.50%
on 08/14/19
+10.73 (+21.78%)
since 12/03/18

Most Recent Stories

More News
ProAmpac Names Rita Cox President of Flexibles Products Division

ProAmpac, a leading global flexible packaging company, today announced that Rita Cox has been named President of the company's Flexibles Products division. Ms. Cox was previously President of the company's...

CBM : 59.99 (unch)
Cambrex Names Thomas Loewald as Chief Executive Officer

Cambrex, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced that Tom Loewald has been named Chief Executive...

CBM : 59.99 (unch)
Global Chiral Chemicals Market Outlook, 2025

, /PRNewswire/ -- The report has been added to offering.

A : 97.89 (+0.37%)
ALB : 88.60 (+3.83%)
BFEHF : 143.1000 (unch)
BASFY : 14.3900 (+2.13%)
CBM : 59.99 (unch)
JMPLD : 70.0000 (-1.41%)
PKI : 122.09 (+1.05%)
WAT : 211.18 (+0.51%)
Cambrex Announces Management Transitions

--Cambrex in Advanced Stages of Search for CEO Successor

CBM : 59.99 (unch)
Nicotine Gum Industry, 2025

, /PRNewswire/ -- The report has been added to offering.

BTI : 33.58 (-0.56%)
CBM : 59.99 (unch)
GSK : 41.21 (-0.07%)
PRGO : 51.98 (-5.70%)
Cambrex Completes Biopharmaceutical Expansion at its Durham, NC Facility

Cambrex, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced it has completed an expansion of its biopharmaceutical...

CBM : 59.99 (unch)
Cambrex Appoints Troy Player as President, Early Stage Development & Testing Business Unit

Cambrex, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced that Troy Player has been appointed as President,...

CBM : 59.99 (unch)
Avid Bioservices Appoints Timothy Compton as Chief Commercial Officer

Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development...

CBM : 59.99 (unch)
CDMO : 7.58 (+1.07%)
CDMOP : 25.47 (+0.47%)
Cambrex Announces Management Changes and Board Appointments

Cambrex Corporation, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced changes to its management team and...

CBM : 59.99 (unch)
Cambrex Announces Completion of Acquisition by the Permira Funds

Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced the completion of its...

CBM : 59.99 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade CBM with:

Business Summary

Cambrex Corporation is an innovative life sciences company with a refreshingly human approach. Driven by passion, their pharmaceutical products, expertise and technologies accelerate customers' small molecule therapeutics into markets across the world. The company offers Active Pharmaceutical Ingredients...

See More

Key Turning Points

2nd Resistance Point 60.00
1st Resistance Point 59.99
Last Price 59.99
1st Support Level 59.98
2nd Support Level 59.98

See More

52-Week High 60.29
Last Price 59.99
Fibonacci 61.8% 50.17
Fibonacci 50% 47.04
Fibonacci 38.2% 43.92
52-Week Low 33.80

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar